ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer

Saturday, June 4, 2016

Submitted by

Mark Ferguson

Source

Source Name: Journal of Thoracic and Cardiovascular Surgery

Source URL: http://www.jtcvsonline.org/article/S0022-5223(16)30035-6/fulltext

Author(s)

Joshua E. Rosen, Michelle C. Salazar, Zuoheng Wang, James B. Yu, Roy H. Decker, Anthony W. Kim, Frank C. Detterbeck, Daniel J. Boffa

The authors used data from the NCDB to assess long-term outcomes after SBRT (1,781) or lobectomy (13,562) for clinical stage I NSCLC in patients without important co-morbidities. Overall survival was significantly better after lobectomy for T1N0 (HR 0.38) and for T2N0 patients (HR 0.38). Propensity score matched patients (1781 pairs) also had significantly better survival at 5-years after lobectomy (59% vs 29%).

Commentary: http://www.jtcvsonline.org/article/S0022-5223(16)30061-7/abstract